Search For "pharmaceuticals"
SkyEc Drugs & Pharma organized a mega vaccination drive on World Rabie
Updated : 4 years, 5 months ago IST
Chennai (Tamil Nadu) [India], October 5 (ANI/Heylin Spark): SkyEc Drugs and Pharmaceuticals Pvt. Ltd., an Indian Multinational pharmaceuticals company recently participated in the World Rabies Day campaign.
Read More
Jaishankar, Colombian counterpart agree to focus on health, pharmaceutical
Updated : 4 years, 5 months ago IST
New Delhi [India], October 2 (ANI): Colombian Vice President and Minister of Foreign Affairs of Colombia, Marta Lucia Ramirez on Saturday met External Affairs Minister S Jaishankar and held wide-ranging discussions on the expanding partnership.
Read More
India-UAE's natural partnership will benefit both countries in terms of op
Updated : 4 years, 5 months ago IST
Dubai [UAE], October 2 (ANI): Union Commerce Minister Piyush Goyal on Saturday said that India and the UAE share a natural partnership that will benefit both countries in terms of various opportunities and employment.
Read More
Glenmark receives marketing approval for Ryaltris®, an innovative com
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris® in 13 countries across the EU and UK.
Read More
Glenmark receives marketing approval for Ryaltris in 13 countries across E
Updated : 4 years, 5 months ago IST
New Delhi [India] September 30 (ANI): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris in 13 countries across the EU and UK.
Read More
MSD Pharmaceuticals launches gender-neutral HPV vaccine in India
Updated : 4 years, 5 months ago IST
Mumbai [Maharashtra], September 29 (ANI): MSD Pharmaceuticals on Wednesday announce the launch of India's first gender-neutral Human Papillomavirus (HPV) vaccine to help reduce HPV-related disease burden in the country.
Read More
Jaishankar meets Mexican President, discusses cooperation in pharma, ICT,
Updated : 4 years, 5 months ago IST
Mexico City [Mexico], September 28 (ANI): External Affairs Minister S Jaishankar met Mexican President Andres Manuel Lopez Obrador on Monday (local time) and discussed expanding practical cooperation in pharmaceuticals, information and communication technology (ICT) and energy.
Read More
Strategic understanding between ZEISS India and QMS Medical Allied Service
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 27 (ANI/BusinessWire India): QMS Medical Allied Services Ltd. today announced their strategic arrangement with ZEISS Medical Technology India - for the screening of Diabetic Retinopathy.
Read More
Apposite wins the coveted Brandon Hall Group Silver Award for excellence i
Updated : 4 years, 6 months ago IST
Hyderabad (Telangana) [India], September 21 (ANI/BusinessWire India): Apposite Learning Solutions, a Hyderabad-based organization is renowned for creating innovative learning solutions for premier clients such as Microsoft, Coromandel, Glenmark Pharmaceuticals, among many others.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate
Updated : 4 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharm
Read More
Glenmark concludes post marketing surveillance (PMS) study on Favipiravir
Updated : 4 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 15 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India.
Read More
Glenmark's post-marketing surveillance shows no safety concerns on use of
Updated : 4 years, 6 months ago IST
New Delhi [India], September 15 (ANI): The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?]) in India for COVID-19 infection.
Read More